Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Collegium Pharma (COLL)

Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Collegium to Participate in Upcoming Investor Conferences

COLL : 30.00 (+0.84%)
Is the Options Market Predicting a Spike in Collegium Pharmaceutical (COLL) Stock?

Investors in Collegium Pharmaceutical, Inc. COLL need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 20, 2024 $20 Put had some of the highest implied...

COLL : 30.00 (+0.84%)
Collegium Pharmaceutical: Q3 Earnings Snapshot

Collegium Pharmaceutical: Q3 Earnings Snapshot

COLL : 30.00 (+0.84%)
Collegium Reports Record Third Quarter 2024 Financial Results

COLL : 30.00 (+0.84%)
Collegium Appoints Vikram Karnani as Chief Executive Officer

COLL : 30.00 (+0.84%)
Corcept Therapeutics Stock Surges 61% in 2024: A Must Buy?

Corcept Therapeutics Incorporated CORT has been having a fabulous 2024, with its share price increasing 60.5% year to date as of Nov. 5, 2024.This company engages in the discovery and development of drugs...

CORT : 56.09 (+3.29%)
COLL : 30.00 (+0.84%)
IONS : 35.40 (+4.89%)
Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024

COLL : 30.00 (+0.84%)
Collingwood Closes Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

COLL : 30.00 (+0.84%)
Collingwood Announces Non-Brokered Private Placement and Board Appointment

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

COLL : 30.00 (+0.84%)
Collegium Pharmaceutical: Q2 Earnings Snapshot

Collegium Pharmaceutical: Q2 Earnings Snapshot

COLL : 30.00 (+0.84%)

Barchart Exclusives

1 Overlooked 'Strong Buy' Dividend Stock to Scoop Up Now
Coca-Cola Europacific Partners (CCEP) has delivered solid revenue growth and is poised for further expansion, making it a strong dividend stock. With a 3.41% dividend yield, a robust geographic presence, and near-unanimous analyst support, CCEP offers a unique blend of income and growth potential that's hard to ignore. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar